Evoke Pharma | DEFA14A: Others
Evoke Pharma | ARS/A: Others
Evoke Pharma | 10-Q: Quarterly report
Evoke Pharma | 8-K: Evoke Pharma Reports First Quarter 2024 Financial Results
Evoke Pharma | 10-K/A: Annual report (Amendment)
Evoke Pharma | 8-K: Current report
Evoke Pharma | ARS: Annual Report to Security Holders
Evoke Pharma | DEFA14A: Others
Evoke Pharma | DEF 14A: Definitive information statements
Evoke Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Evoke Pharma | 424B3: Prospectus
Evoke Pharma | 8-K: Current report
Evoke Pharma | 8-K: Current report
Evoke Pharma | 8-K: Current report
Evoke Pharma | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement
Evoke Pharma | 424B3: Prospectus
Evoke Pharma | 10-K: Annual report
Evoke Pharma | 8-K: Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Evoke Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Laurence W. Lytton(9.99%)
Evoke Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals
No Data